The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of the tumor microenvironment landscape and deep learning-guided prediction of prognosis in lung adenocarcinoma with bulk RNA sequencing data.
 
Philippe Gui
No Relationships to Disclose
 
Wei Wu
No Relationships to Disclose
 
Elizabeth Yu
No Relationships to Disclose
 
Caroline Elizabeth McCoach
Honoraria - Genentech; Novartis
Speakers' Bureau - Novartis
Research Funding - Novartis; Revolution Medicines
Travel, Accommodations, Expenses - Lilly; Loxo; Takeda
 
Robert Charles Doebele
Stock and Other Ownership Interests - Rain Therapeutics
Consulting or Advisory Role - AstraZeneca; Bayer; GreenPeptide; Ignyta; OncoMed; Rain Therapeutics; Roche/Genentech; Takeda
Research Funding - Ignyta (Inst)
Patents, Royalties, Other Intellectual Property - Licensing fees for biologic materials from Black Diamond (Inst); Licensing fees for biologic materials from Foundation Medicine (Inst); Licensing fees for biologic materials from Genentech (Inst); Licensing fees for patent from Rain Therapeutics; Licensing Fees from Abbott Molecular for Patent PCT/US2013/057495; Licensing fees from Ignyta for biologic materials (Inst)
Travel, Accommodations, Expenses - Ignyta; Rain Therapeutics; Roche/Genentech
 
Trever G. Bivona
Honoraria - AstraZeneca; Jazz Pharmaceuticals; Novartis; Revolution Medicines; SpringWorks Therapeutics; Strategia; Takeda
Consulting or Advisory Role - AstraZeneca; Jazz Pharmaceuticals; Novartis; Revolution Medicines; SpringWorks Therapeutics; Strategia; Takeda
Research Funding - Novartis; Revolution Medicines
Travel, Accommodations, Expenses - Novartis; Revolution Medicines